Hydroxyproline Market: Growth Drivers and Challenges
Growth Drivers
- Rising Adoption of Collagen-Based Products – Hydroxyproline (HYP) is a collagen part of the protein and has an important role to play in the stabilization of the triple helix of collagen. For instance, hydroxyproline is also a type of non-essential amino acid, accounting for approximately 13% of the total amino acids of collagen.
- Growing Geriatric Population- One of the most well-established indicators of bone resorption may be the growing knowledge among the older population of the significance of hydroxyproline which is possibly known for preserving healthy joints and bones.
- Surging Prevalence of Liver Fibrosis- Most often, hydroxyproline is employed as a liver fibrosis diagnostic marker, which is the excessive build-up of collagen-primarily extracellular matrix (ECM) proteins.
- Hydroxyproline in Dietary Supplements- Hydroxyproline is utilized as a source of dietary protein in the food business to promote collagen formation, skin health, and joint health to lessen aging symptoms and enhance skin health.
Challenges
- Side Effects associated with Hydroxyproline- A dietary supplement called hydroxyproline if used in high dosages, can have some very detrimental adverse effects including fatigue, headaches, dizziness, nausea, vomiting, diarrhea, and may raise blood pressure. Other side effects may also include heartburn and decreased appetite. In addition, rashes, pimples, and inflammation are common side effects of peptide synthesis on the skin that include swelling of the tongue or skin, stinging or tingling in the mouth, or on the skin where collagen is administered.
- Lack of sensitivity at low concentrations can impact quality control processes
- Huge Percentage of Variability can lead to inconsistent quality of the product
- Restriction of Consumption in Various Occasions
Hydroxyproline Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.7% |
|
Base Year Market Size (2024) |
USD 77.64 million |
|
Forecast Year Market Size (2037) |
USD 159.61 million |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of hydroxyproline is assessed at USD 81.4 million.
The hydroxyproline market size was over USD 77.64 million in 2024 and is projected to reach USD 159.61 million by 2037, witnessing around 5.7% CAGR during the forecast period i.e., between 2025-2037. Growing beauty industry across the globe and growing sales of smartwatches will drive the market growth.
Asia Pacific industry is predicted to dominate majority revenue share of 40% by 2037, impelled by growing production and consumption of chemicals in the region.
The major players in the market are Henan Senyuan Group Co., Ltd., Evonik Industries AG, Fengchen Group Co.,Ltd, Merck Group, Thermo Fisher Scientific Holdings, Inc., EnColl Corporation, Wuxi Jingyao Biotechnology Co., Ltd., BASF SE, Wuhan Dico Chemical Co., Ltd., and others.